Outcomes and Prognostic Factors of First-Line Combination of Immune Checkpoint Inhibitors (icis) and Tyrosine Kinase Inhibitors (tkis) in TFE3-rearranged Renal Cell Carcinoma.

Junjie Zhao, Yanfeng Tang,Xu Hu,Junru Chen, Haoyang Liu,Haolin Liu,Jiayu Liang,Xingming Zhang,Jinge Zhao,Pengfei Shen,Zhenhua Liu,Guangxi Sun,Hao Zeng

JOURNAL OF CLINICAL ONCOLOGY（2024）

引用 0|浏览4

暂无评分

关键词

261-566-3248-9542-427-2615-2418,261-566-3248-9559-9794,261-566-3248-9542-427-2615-2418,283-2494,130-540-543-4790,3282-270-151-3424,3282-206-3896-11575,283-424-3231,38092-33675,38092-18384,38092-27449,12

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要